South Africa's Bidvest makes $515M bid for rest of Adcock Ingram

South African conglomerate Bidvest has offered about $515 million for the shares it does not already own in drugmaker Adcock Ingram in a new attempt to build a big presence in the pharmaceutical market.

The deal would give Bidvest a substantial presence in the generic market, which is set to grow as the government prepares a national health insurance plan that would rely on the use of cut-price versions of branded drugs.

Read more: Bidvest makes $515 million bid for rest of Adcock Ingram – Yahoo News.